[HTML][HTML] Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets

M Farahani, Z Niknam, LM Amirabad… - Biomedicine & …, 2022 - Elsevier
Deciphering the molecular downstream consequences of severe acute respiratory
syndrome coronavirus (SARS-CoV)− 2 infection is important for a greater understanding of …

JAK-STAT pathway inhibition and their implications in COVID-19 therapy

S Satarker, AA Tom, RA Shaji, A Alosious… - Postgraduate …, 2021 - Taylor & Francis
As the incidence of COVID-19 increases with time, more and more efforts are made to pave
a way out for the therapeutic strategies to deal with the disease progression. Inflammation …

Baricitinib restrains the immune dysregulation in patients with severe COVID-19

V Bronte, S Ugel, E Tinazzi, A Vella… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Patients with coronavirus disease 2019 (COVID-19) develop pneumonia
generally associated with lymphopenia and a severe inflammatory response due to …

The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19

C Perricone, P Triggianese, E Bartoloni, G Cafaro… - Journal of …, 2020 - Elsevier
The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection has posed the world at a pandemic risk. Coronavirus-19 disease (COVID-19) is an …

Sex drives dimorphic immune responses to viral infections

S Ghosh, RS Klein - The journal of immunology, 2017 - journals.aai.org
New attention to sexual dimorphism in normal mammalian physiology and disease has
uncovered a previously unappreciated breadth of mechanisms by which females and males …

The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?

G Morris, CC Bortolasci, BK Puri, W Marx, A O'Neil… - Cytokine, 2021 - Elsevier
An analysis of published data appertaining to the cytokine storms of COVID-19, H1N1
influenza, cytokine release syndrome (CRS), and macrophage activation syndrome (MAS) …

Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK/STAT and TGFB signaling pathways

MN Aydemir, HB Aydemir, EM Korkmaz, M Budak… - Gene Reports, 2021 - Elsevier
Recently an outbreak that emerged in Wuhan, China in December 2019, spread to the
whole world in a short time and killed> 1,410,000 people. It was determined that a new type …

Interplay between Janus kinase/signal transducer and activator of transcription signaling activated by type I interferons and viral antagonism

Y Nan, C Wu, YJ Zhang - Frontiers in immunology, 2017 - frontiersin.org
Interferons (IFNs), which were discovered a half century ago, are a group of secreted
proteins that play key roles in innate immunity against viral infection. The major signaling …

Fine-tuning of type I interferon response by STAT3

MH Tsai, LM Pai, CK Lee - Frontiers in immunology, 2019 - frontiersin.org
Type I interferon (IFN-I) is induced during innate immune response and is required for
initiating antiviral activity, growth inhibition, and immunomodulation. STAT1, STAT2, and …

[HTML][HTML] PDIA3: Structure, functions and its potential role in viral infections

F Mahmood, R Xu, MUN Awan, Y Song, Q Han… - Biomedicine & …, 2021 - Elsevier
The catalysis of disulphide (single bondSsingle bondSsingle bond) bonds is the most
important characteristic of protein disulphide isomerase (PDI) family. Catalysis occurs in the …